Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference

Ardelyx (ARDX) has announced its participation in the Piper Sandler 36th Annual Healthcare Conference.

Rhea-AI Summary

Ardelyx (ARDX) has announced its participation in the Piper Sandler 36th Annual Healthcare Conference. The company's Chief Financial and Operations Officer, Justin Renz, and Chief Commercial Officer, Eric Foster, will engage in a fireside chat on Wednesday, December 4, 2024, at 12:30pm EST in New York City.

The presentation will be accessible via live webcast on the Events and Presentations page of Ardelyx's website, with a replay available for 30 days following the event.

Argus Session date unavailable

+2.71% session move Open Argus

Details

News Market Reaction – ARDX

The recorded move for ARDX in the trading session of this news was +2.71%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WALTHAM, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Justin Renz, Chief Financial and Operations Officer, and Eric Foster, Chief Commercial Officer, will participate in a fireside chat at the Piper Sandler 36^th Annual Healthcare Conference on Wednesday, December 4, 2024 at 12:30pm EST in New York City.

To access the live webcast of the panel presentation please visit the Events and Presentations page within the Ardelyx website at https://ir.ardelyx.com/events-and-presentations. A replay of the panel presentation will be available on the Ardelyx website for 30 days following the event.

About Ardelyx, Inc.
Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA^® (tenapanor) and XPHOZAH^® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL^® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. For more information, please visit https://ardelyx.com/ and connect with us on X (formerly known as Twitter), LinkedIn and Facebook.

Investor and Media Contacts:
Caitlin Lowie
clowie@ardelyx.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Ardelyx (ARDX) presenting at the Piper Sandler Healthcare Conference 2024?

Ardelyx (ARDX) will present at the Piper Sandler Healthcare Conference on Wednesday, December 4, 2024, at 12:30pm EST in New York City.

How can I watch Ardelyx's (ARDX) presentation at the Piper Sandler Conference?

You can watch the presentation through a live webcast available on Ardelyx's website at their Events and Presentations page (ir.ardelyx.com/events-and-presentations).

How long will Ardelyx's (ARDX) Piper Sandler Conference presentation be available for replay?

The presentation replay will be available on Ardelyx's website for 30 days following the event.

Which Ardelyx (ARDX) executives are participating in the Piper Sandler Healthcare Conference?

Justin Renz, Chief Financial and Operations Officer, and Eric Foster, Chief Commercial Officer, will participate in the conference.